Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Gut
|
May 1, 1992
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis
A J Macpherson, K A Chester, L Robson, et al.
Journal of Immunological Methods
|
February 13, 1995
Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography
J L Casey, P A Keep, K A Chester, et al.
Bioconjugate Chemistry
|
May 1, 2009
Site-specific polysialylation of an antitumor single-chain Fv fragment
A Constantinou, A A Epenetos, D Hreczuk-Hirst, et al.
The Journal of Pathology
|
December 1, 1992
Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas
A M Abbasi, K A Chester, A J MacPherson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody
A Mayer, K A Chester, J Bhatia, et al.
Journal of Cell Science
|
June 1, 1992
Mitochondrial gene expression in the human gastrointestinal tract
A J Macpherson, T P Mayall, K A Chester, et al.
Human Gene Therapy
|
February 24, 1998
Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody
H Konishi, T Ochiya, K A Chester, et al.
Cancer Research
|
April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex
S P Cooke, G M Boxer, L Lawrence, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells
A M Abbasi, K A Chester, I C Talbot, et al.
British Journal of Cancer
|
May 27, 2004
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
A Mayer, S K Sharma, B Tolner, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Gut
|
May 1, 1992
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis
A J Macpherson, K A Chester, L Robson, et al.
Journal of Immunological Methods
|
February 13, 1995
Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography
J L Casey, P A Keep, K A Chester, et al.
Bioconjugate Chemistry
|
May 1, 2009
Site-specific polysialylation of an antitumor single-chain Fv fragment
A Constantinou, A A Epenetos, D Hreczuk-Hirst, et al.
The Journal of Pathology
|
December 1, 1992
Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas
A M Abbasi, K A Chester, A J MacPherson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody
A Mayer, K A Chester, J Bhatia, et al.
Journal of Cell Science
|
June 1, 1992
Mitochondrial gene expression in the human gastrointestinal tract
A J Macpherson, T P Mayall, K A Chester, et al.
Human Gene Therapy
|
February 24, 1998
Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody
H Konishi, T Ochiya, K A Chester, et al.
Cancer Research
|
April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex
S P Cooke, G M Boxer, L Lawrence, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells
A M Abbasi, K A Chester, I C Talbot, et al.
British Journal of Cancer
|
May 27, 2004
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
A Mayer, S K Sharma, B Tolner, et al.
Page
of 4